港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

維升藥業-B

19.980

0.000

成交量：1,200

成交額：2.40萬

市值：22.78億

市盈率：-8.19

高：19.980

開：19.980

低：19.980

收：19.980

52周最高：47.100

52周最低：18.500

股本：1.14億

香港流通股本：1.14億

量比：0.30

換手率：0.00%

股息：- -

股息率：- -

每股收益(LYR):-2.440

淨資產收益率：-50.52%

總資產收益率：-23.58%

市淨率：2.56

市盈率(LYR):-8.19

市銷率: 14363.47

資料載入中...

總覽公司新聞資訊公告

維升藥業-B(02561.HK)擬8月27日舉行董事會會議以審批中期業績

維昇藥業-B擬於8月27日召開董事會審議2026年中期業績

維昇藥業-B更新7月股份變動月報表，股本維持穩定

港股異動 | 維升藥業-B(02561)升逾5% 維臻高®商業化銷售逐步放量公司將實現向「產品兑現」穩步過渡

維升藥業-B(02561)授出合共 51.41萬份股份獎勵

維昇藥業-B（02561）向19名員工授出51.41萬股獎勵股份

港股異動 | 維升藥業-B(02561)盤中升逾7% 北京大學第三醫院正式引進全球首款PTH療法「帕羅培特立帕肽」

智通财经网

維升藥業－Ｂ(02561)股價顯著下跌12.653%，現價港幣$20.02

阿斯达克财经

維昇藥業-B更新6月股份變動月報，總股本維持穩定

維升藥業-B（02561）盤中漲近30%背後：市場聚焦核心產品放量，維臻高®商業化再提速

維升藥業－Ｂ(02561)股價大幅上升29.129%，現價港幣$25.8

阿斯达克财经

港股異動 | 維升藥業-B(02561)早盤升逾15% 公司近期與鎂信健康達成項目合作探索多元支付新模式

港股異動 | 維升藥業-B(02561.HK)早盤升逾15% 公司近期與鎂信健康達成項目合作探索多元支付新模式

ESG獎項背後的價值錨點，是維升藥業-B(2561.HK)臨床價值與商業效率的雙重印證

維升藥業-B(02561)6月29日斥資8.46萬港元回購4300股

維昇藥業-B 6月29日回購約0.43萬股，耗資約8.46萬港元

維升藥業-B(02561)委任Roy Paul Khoury、Sherrie Lynn Glass及Michael J. Chang為非執行董事

維昇藥業-B6月23日回購0.40萬股股份，涉資約7.68萬港元

維升藥業-B(02561)6月23日斥資約7.68萬港元回購4000股

維昇藥業-B：6月22日回購4,800股，涉資約9.50萬港元

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/02561/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02561","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02561\",,,,,undefined,":{"symbol":"02561","market":"HK","secType":"STK","nameCN":"維升藥業-B","latestPrice":19.98,"timestamp":1787639860541,"preClose":19.98,"halted":0,"volume":1200,"delay":0,"changeRate":0,"floatShares":113999999,"shares":113999999,"eps":-2.44,"marketStatus":"交易中","change":0,"latestTime":"08-25 14:58:38","open":19.98,"high":19.98,"low":19.98,"amount":23976,"amplitude":0,"askPrice":19.99,"askSize":300,"bidPrice":19.95,"bidSize":100,"shortable":3,"etf":0,"ttmEps":-2.466,"tradingStatus":2,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1787645400000},"marketStatusCode":2,"adr":0,"listingDate":1742486400000,"exchange":"SEHK","adjPreClose":19.98,"openAndCloseTimeList":[[1787621400000,1787630400000],[1787634000000,1787644800000]],"volumeRatio":0.302905,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02561\",,,,,undefined,":{"symbol":"02561","floatShares":113999999,"roa":"-23.58%","roe":"-50.52%","lyrEps":-2.44,"volumeRatio":0.302905,"shares":113999999,"dividePrice":0,"high":19.98,"amplitude":0,"preClose":19.98,"low":19.98,"week52Low":18.5,"pbRate":"2.56","psRate":"14363.47","week52High":47.1,"institutionHeld":0,"latestPrice":19.98,"committee":-0.5,"eps":-2.44,"divideRate":0,"volume":1200,"delay":0,"ttmEps":-2.466,"open":19.98,"prevYearClose":32.8,"prevWeekClose":19.98,"prevMonthClose":19.26,"prevQuarterClose":19.98,"fiveDayClose":19.99,"twentyDayClose":20,"sixtyDayClose":22.94,"earningDate":1787760000000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02561\",params:#limit:5,,,undefined,":[{"date":"2026-08-27","symbol":"02561","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787794200000,"name":null,"time":"","dateTimestamp":1787760000000,"actualEps":null},{"date":"2026-03-12","symbol":"02561","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1773279000000,"name":null,"time":"","dateTimestamp":1773244800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02561\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02561\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1746460800000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02561\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02561","date":"2026-08-24","current":-8.10219,"percent":0.935673,"low":-30.760225,"twenty":-26.667723,"median":-15.292874,"eighty":-9.20127,"high":-7.021664,"avg":-17.246317,"sd":7.547994,"marketCap":2178526572},"quantilePoints":[{"date":"2025-04-03","current":-21.475965,"twenty":-22.637245,"median":-22.569747,"eighty":-22.098421,"marketCap":5724824916},{"date":"2025-04-11","current":-18.134639,"twenty":-22.558476,"median":-18.349759,"eighty":-18.045823,"marketCap":4802017317},{"date":"2025-04-17","current":-25.787715,"twenty":-25.955056,"median":-22.513392,"eighty":-18.141011,"marketCap":4682394110},{"date":"2025-04-25","current":-29.965674,"twenty":-27.695216,"median":-22.653961,"eighty":-18.190408,"marketCap":5445704099},{"date":"2025-05-02","current":-28.244363,"twenty":-27.861811,"median":-26.066617,"eighty":-18.349759,"marketCap":5143797909},{"date":"2025-05-09","current":-27.581562,"twenty":-28.248468,"median":-27.028836,"eighty":-20.850724,"marketCap":5058352761},{"date":"2025-05-16","current":-27.481285,"twenty":-28.307048,"median":-27.470681,"eighty":-22.305907,"marketCap":5081138134},{"date":"2025-05-23","current":-29.180898,"twenty":-28.483617,"median":-27.481285,"eighty":-22.603559,"marketCap":5411526040},{"date":"2025-05-30","current":-27.585218,"twenty":-28.483617,"median":-27.495492,"eighty":-22.648389,"marketCap":5138101566},{"date":"2025-06-06","current":-26.147365,"twenty":-28.307048,"median":-27.481285,"eighty":-24.987287,"marketCap":5212154028},{"date":"2025-06-13","current":-28.707887,"twenty":-28.307048,"median":-27.486097,"eighty":-25.744296,"marketCap":5724824916},{"date":"2025-06-20","current":-27.87701,"twenty":-28.483617,"median":-27.500076,"eighty":-26.010837,"marketCap":5548238276},{"date":"2025-06-27","current":-26.600431,"twenty":-28.46744,"median":-27.491566,"eighty":-26.131215,"marketCap":5308991862},{"date":"2025-07-04","current":-25.999842,"twenty":-28.345085,"median":-27.470681,"eighty":-26.039907,"marketCap":5189368655},{"date":"2025-07-11","current":-25.483255,"twenty":-28.252573,"median":-27.442177,"eighty":-25.700877,"marketCap":5081138134},{"date":"2025-07-18","current":-27.275886,"twenty":-28.168194,"median":-27.211053,"eighty":-25.700877,"marketCap":5434311412},{"date":"2025-07-25","current":-27.917728,"twenty":-28.10544,"median":-27.177054,"eighty":-25.808828,"marketCap":5582416336},{"date":"2025-08-01","current":-26.858726,"twenty":-28.252573,"median":-27.236899,"eighty":-25.835301,"marketCap":5337473578},{"date":"2025-08-08","current":-26.45431,"twenty":-28.168194,"median":-27.174901,"eighty":-25.937332,"marketCap":5270256728},{"date":"2025-08-15","current":-27.513449,"twenty":-28.142473,"median":-27.236899,"eighty":-26.012565,"marketCap":5473046546},{"date":"2025-08-22","current":-26.703746,"twenty":-28.118557,"median":-27.177054,"eighty":-26.021282,"marketCap":5295320638},{"date":"2025-08-29","current":-26.119434,"twenty":-28.10544,"median":-27.144467,"eighty":-26.021282,"marketCap":5204179147},{"date":"2025-09-05","current":-23.791598,"twenty":-28.093765,"median":-27.114576,"eighty":-25.835301,"marketCap":4735670561},{"date":"2025-09-12","current":-23.381705,"twenty":-28.083375,"median":-27.05699,"eighty":-25.694259,"marketCap":4662460107},{"date":"2025-09-19","current":-23.051901,"twenty":-28.060478,"median":-27.021811,"eighty":-25.478949,"marketCap":4593433106},{"date":"2025-09-26","current":-21.933119,"twenty":-28.003961,"median":-26.881441,"eighty":-23.835003,"marketCap":4359159651},{"date":"2025-10-03","current":-19.179371,"twenty":-27.951558,"median":-26.814509,"eighty":-23.612343,"marketCap":4545323379},{"date":"2025-10-10","current":-18.42629,"twenty":-27.909584,"median":-26.722604,"eighty":-23.450061,"marketCap":4360487033},{"date":"2025-10-17","current":-18.280755,"twenty":-27.87397,"median":-26.671617,"eighty":-23.093007,"marketCap":4322679342},{"date":"2025-10-24","current":-17.856771,"twenty":-27.855424,"median":-26.557884,"eighty":-22.535934,"marketCap":4223959260},{"date":"2025-10-31","current":-16.854881,"twenty":-27.829876,"median":-26.452186,"eighty":-21.933119,"marketCap":3992912259},{"date":"2025-11-07","current":-16.17341,"twenty":-27.822718,"median":-26.363703,"eighty":-19.806882,"marketCap":3829078931},{"date":"2025-11-14","current":-14.606062,"twenty":-27.750423,"median":-26.249352,"eighty":-18.799844,"marketCap":3467805439},{"date":"2025-11-21","current":-13.329485,"twenty":-27.732081,"median":-26.119434,"eighty":-18.28655,"marketCap":3163243483},{"date":"2025-11-28","current":-13.563448,"twenty":-27.641863,"median":-26.021242,"eighty":-18.15057,"marketCap":3230457156},{"date":"2025-12-05","current":-15.697088,"twenty":-27.585218,"median":-25.856964,"eighty":-18.047863,"marketCap":3745061840},{"date":"2025-12-12","current":-16.915932,"twenty":-27.581562,"median":-25.811068,"eighty":-17.856771,"marketCap":4043322514},{"date":"2025-12-19","current":-15.561133,"twenty":-27.572592,"median":-25.748021,"eighty":-17.298197,"marketCap":3728258422},{"date":"2025-12-24","current":-15.871137,"twenty":-27.537106,"median":-25.592118,"eighty":-16.909424,"marketCap":3814375940},{"date":"2026-01-02","current":-14.633696,"twenty":-27.513319,"median":-25.499704,"eighty":-16.617104,"marketCap":3530818257},{"date":"2026-01-09","current":-14.6234,"twenty":-27.507904,"median":-25.36554,"eighty":-16.251482,"marketCap":3537119539},{"date":"2026-01-16","current":-14.627967,"twenty":-27.496935,"median":-23.827768,"eighty":-15.946573,"marketCap":3549722103},{"date":"2026-01-23","current":-16.340142,"twenty":-27.491697,"median":-23.637534,"eighty":-15.766708,"marketCap":3961405850},{"date":"2026-01-30","current":-14.661628,"twenty":-27.487059,"median":-23.520828,"eighty":-15.582389,"marketCap":3570726376},{"date":"2026-02-06","current":-14.624534,"twenty":-27.472802,"median":-23.381705,"eighty":-15.41764,"marketCap":3570726376},{"date":"2026-02-13","current":-14.275853,"twenty":-27.453945,"median":-23.154666,"eighty":-15.203628,"marketCap":3505613130},{"date":"2026-02-20","current":-14.390669,"twenty":-27.447813,"median":-22.932516,"eighty":-15.172676,"marketCap":3528717830},{"date":"2026-02-27","current":-13.887168,"twenty":-27.442691,"median":-22.626101,"eighty":-15.007296,"marketCap":3442600311},{"date":"2026-03-06","current":-13.692525,"twenty":-27.436603,"median":-22.183333,"eighty":-14.876498,"marketCap":3366984929},{"date":"2026-03-13","current":-13.213121,"twenty":-27.307751,"median":-21.922595,"eighty":-14.759688,"marketCap":3264063993},{"date":"2026-03-20","current":-11.103996,"twenty":-27.213507,"median":-20.641424,"eighty":-14.63255,"marketCap":2732655891},{"date":"2026-03-27","current":-11.448917,"twenty":-27.181226,"median":-19.179371,"eighty":-14.605,"marketCap":2810371700},{"date":"2026-04-02","current":-10.551094,"twenty":-27.175762,"median":-18.799844,"eighty":-14.511725,"marketCap":2602429399},{"date":"2026-04-10","current":-10.816815,"twenty":-27.169165,"median":-18.593258,"eighty":-14.452927,"marketCap":2688546918},{"date":"2026-04-17","current":-11.124817,"twenty":-27.145519,"median":-18.28655,"eighty":-14.356143,"marketCap":2766262727},{"date":"2026-04-24","current":-9.234794,"twenty":-27.140301,"median":-18.19085,"eighty":-14.276426,"marketCap":2684450661},{"date":"2026-04-30","current":-10.01242,"twenty":-27.130647,"median":-18.142604,"eighty":-14.218852,"marketCap":2911244218},{"date":"2026-05-08","current":-9.36492,"twenty":-27.114576,"median":-18.115304,"eighty":-13.966752,"marketCap":2732426221},{"date":"2026-05-15","current":-8.609823,"twenty":-27.082531,"median":-17.966643,"eighty":-13.803569,"marketCap":2518716908},{"date":"2026-05-22","current":-8.965761,"twenty":-27.063435,"median":-17.856771,"eighty":-13.603795,"marketCap":2616848736},{"date":"2026-05-29","current":-8.540077,"twenty":-27.053123,"median":-17.713814,"eighty":-13.46708,"marketCap":2501271250},{"date":"2026-06-05","current":-7.806526,"twenty":-27.033178,"median":-17.267927,"eighty":-13.258871,"marketCap":2289742644},{"date":"2026-06-12","current":-7.462138,"twenty":-27.023216,"median":-16.915932,"eighty":-12.86922,"marketCap":2187249401},{"date":"2026-06-18","current":-7.459122,"twenty":-27.00271,"median":-16.854881,"eighty":-11.79522,"marketCap":2191610816},{"date":"2026-06-26","current":-7.402496,"twenty":-26.938483,"median":-16.535359,"eighty":-11.467287,"marketCap":2164351975},{"date":"2026-07-03","current":-9.845227,"twenty":-26.885983,"median":-16.403537,"eighty":-11.112324,"marketCap":2880714316},{"date":"2026-07-10","current":-7.559024,"twenty":-26.848658,"median":-16.17341,"eighty":-10.890961,"marketCap":2209056474},{"date":"2026-07-17","current":-7.138134,"twenty":-26.818319,"median":-16.023664,"eighty":-10.603064,"marketCap":2093478988},{"date":"2026-07-24","current":-7.09936,"twenty":-26.773863,"median":-15.932493,"eighty":-9.912104,"marketCap":2082575452},{"date":"2026-07-31","current":-7.145258,"twenty":-26.733919,"median":-15.871137,"eighty":-9.576471,"marketCap":2100021110},{"date":"2026-08-07","current":-7.309141,"twenty":-26.699986,"median":-15.586393,"eighty":-9.407001,"marketCap":2152358085},{"date":"2026-08-14","current":-7.396048,"twenty":-26.682279,"median":-15.561133,"eighty":-9.341935,"marketCap":2180707280},{"date":"2026-08-21","current":-7.372359,"twenty":-26.66967,"median":-15.311996,"eighty":-9.225752,"marketCap":2178526572},{"date":"2026-08-24","current":-7.375014,"twenty":-26.667723,"median":-15.292874,"eighty":-9.20127,"marketCap":2178526572}],"updateTime":1787619824157},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02561\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660865794","title":"維升藥業-B(02561.HK)擬8月27日舉行董事會會議以審批中期業績","url":"https://stock-news.laohu8.com/highlight/detail?id=2660865794","media":"中金财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660865794?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 17:17","pubTimestamp":1786958226,"startTime":"0","endTime":"0","summary":"格隆汇8月17日丨维升药业-B(02561.HK)公告，谨定于2026年8月27日(星期四)举行董事会会议，以考虑及通过集团截至2026年6月30日止6个月中期业绩，以及处理其他事项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260817/32337218.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["02561","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195388155","title":"維昇藥業-B擬於8月27日召開董事會審議2026年中期業績","url":"https://stock-news.laohu8.com/highlight/detail?id=1195388155","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195388155?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 16:36","pubTimestamp":1786955768,"startTime":"0","endTime":"0","summary":"维昇药业-B8月17日公告称，公司董事会已排期于2026年8月27日（星期四）召开会议，审议并通过本集团截至2026年6月30日止六个月的中期业绩，并处理其他相关事项。公司强调，香港交易及结算所有限公司及香港联合交易所有限公司对本公告内容概不负责，对其准确性或完整性亦不发表任何声明，并且明确表示不承担任何因依赖该公告而产生的损失责任。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1190158216","title":"維昇藥業-B更新7月股份變動月報表，股本維持穩定","url":"https://stock-news.laohu8.com/highlight/detail?id=1190158216","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190158216?lang=zh_tw&edition=fundamental","pubTime":"2026-08-03 16:59","pubTimestamp":1785747590,"startTime":"0","endTime":"0","summary":"维昇药业-B于2026年8月3日发布截至2026年7月31日的股份变动月报表。已发行普通股数量为113,753,364股，库藏股数量为173,500股，合计113,926,864股，与上月底持平。维昇药业-B表示，本次股份变动事项均已符合香港联交所《上市规则》及其他适用法律法规的规定。截至2026年7月31日，公司总股本结构保持稳定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654902660","title":"港股異動 | 維升藥業-B(02561)升逾5% 維臻高®商業化銷售逐步放量 公司將實現向「產品兑現」穩步過渡","url":"https://stock-news.laohu8.com/highlight/detail?id=2654902660","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654902660?lang=zh_tw&edition=fundamental","pubTime":"2026-07-27 15:40","pubTimestamp":1785138023,"startTime":"0","endTime":"0","summary":"消息面上，此前维升药业核心产品长效生长激素隆培生长激素正式获批上市，适用于3岁及以上儿童、青少年生长激素缺乏症的治疗，也意味着维升药业开始进入商业化兑现周期。随着维臻高的商业化销售逐步放量并贡献业绩收入，公司将实现向“产品兑现”的稳步过渡，其估值中枢亦将随之获得更为坚实的基本面支撑。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1472528.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["KCAI","BK4588","BK4585","02561","VXUS","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652215574","title":"維升藥業-B(02561)授出合共 51.41萬份股份獎勵","url":"https://stock-news.laohu8.com/highlight/detail?id=2652215574","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652215574?lang=zh_tw&edition=fundamental","pubTime":"2026-07-20 20:33","pubTimestamp":1784550839,"startTime":"0","endTime":"0","summary":"智通财经APP讯，维升药业-B(02561)发布公告，于2026年7月20日，本公司根据本计划向19名为本公司高级管理层及本集团雇员的合资格承授人(承授人)授出合共 51.41万份股份奖励，惟须待承授人接纳方可作实。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1469987.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02561","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1128799711","title":"維昇藥業-B（02561）向19名員工授出51.41萬股獎勵股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1128799711","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128799711?lang=zh_tw&edition=fundamental","pubTime":"2026-07-20 20:31","pubTimestamp":1784550717,"startTime":"0","endTime":"0","summary":"2026年7月20日，维昇药业-B公告称，董事会根据公司首次公开发售后股份奖励计划，于同日向19名公司高级管理层及集团员工授出合计514,068份股份奖励，认购价为零。授出当日公司股份收市价为每股18.90港元。根据奖励计划规定，股份奖励自公司股份于2025年3月21日上市之日起10年内有效，所有在2035年3月21日前仍未归属的奖励股份将被无代价没收。根据公告，本次授予已获董事会批准，且不涉及向任何承授人提供财务资助。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649195162","title":"港股異動 | 維升藥業-B(02561)盤中升逾7% 北京大學第三醫院正式引進全球首款PTH療法「帕羅培特立帕肽」","url":"https://stock-news.laohu8.com/highlight/detail?id=2649195162","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649195162?lang=zh_tw&edition=fundamental","pubTime":"2026-07-08 10:03","pubTimestamp":1783476228,"startTime":"0","endTime":"0","summary":"维升药业-B(02561)盘中涨超7%，截至发稿，涨4.7%，报20.96港元。","market":"sg","thumbnail":"https://img.zhitongcaijing.com/image/20260708/20260708100848_58643.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260708/20260708100848_58643.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1464517.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4585","BK1161","KCAI","VXUS","02561","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649008336","title":"維升藥業－Ｂ(02561)股價顯著下跌12.653%，現價港幣$20.02","url":"https://stock-news.laohu8.com/highlight/detail?id=2649008336","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649008336?lang=zh_tw&edition=fundamental","pubTime":"2026-07-07 15:50","pubTimestamp":1783410600,"startTime":"0","endTime":"0","summary":"[下跌股]维升药业－Ｂ(02561) 股价在下午03:49比前收市价显著下跌12.653%，现股价为港币$20.02。至目前为止，今日最高价为$22.6，而最低价为$20.02。总成交量为4.7万股，总成交金额为港币$100.507万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152742524_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152742524_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2607073962/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2607073962/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151732439","title":"維昇藥業-B更新6月股份變動月報，總股本維持穩定","url":"https://stock-news.laohu8.com/highlight/detail?id=1151732439","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151732439?lang=zh_tw&edition=fundamental","pubTime":"2026-07-06 16:53","pubTimestamp":1783327999,"startTime":"0","endTime":"0","summary":"维昇药业-B于2026年7月6日披露截至2026年6月30日的股份变动月报。公告显示，公司法定股本为500,000,000股普通股，面值为每股0.0001美元，合计50,000美元，与上月一致。本月末已发行股份共计113,753,364股，较上月减少123,800股；库存股份数由49,700股增至173,500股，总股本维持在113,926,864股不变。报告期内未有新增发售或注销情况，相关股份变动主要由于公司在6月回购合计123,800股并将其持作库存股份。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648090055","title":"維升藥業-B（02561）盤中漲近30%背後：市場聚焦核心產品放量，維臻高®商業化再提速","url":"https://stock-news.laohu8.com/highlight/detail?id=2648090055","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648090055?lang=zh_tw&edition=fundamental","pubTime":"2026-07-02 18:32","pubTimestamp":1782988323,"startTime":"0","endTime":"0","summary":"7月2日，港股医药板块全线爆发，其中维升药业-B盘中放量飙升近30%，领跑整个创新药板块。截至当日收市，维升药业全日涨幅达25.13%，收至25港元，表现十分亮眼。今年1月，公司核心产品长效生长激素隆培生长激素正式获批上市，适用于3岁及以上儿童、青少年生长激素缺乏症的治疗，也意味着维升药业开始进入商业化兑现周期。2026年维升药业正以进口方式进行商业化，计划2028年实现技术转移及本地化生产。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1462440.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02561","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648790885","title":"維升藥業－Ｂ(02561)股價大幅上升29.129%，現價港幣$25.8","url":"https://stock-news.laohu8.com/highlight/detail?id=2648790885","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648790885?lang=zh_tw&edition=fundamental","pubTime":"2026-07-02 13:10","pubTimestamp":1782969000,"startTime":"0","endTime":"0","summary":"[上升股]维升药业－Ｂ(02561) 股价在下午01:10比前收市价大幅上升29.129%，现股价为港币$25.8。至目前为止，今日最高价为$25.8，而最低价为$19.13。总成交量为13.06万股，总成交金额为港币$296.56万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152547499_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2607025115/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2607025115/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02561","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648573106","title":"港股異動 | 維升藥業-B(02561)早盤升逾15% 公司近期與鎂信健康達成項目合作 探索多元支付新模式","url":"https://stock-news.laohu8.com/highlight/detail?id=2648573106","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648573106?lang=zh_tw&edition=fundamental","pubTime":"2026-07-02 10:31","pubTimestamp":1782959502,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，维升药业-B早盘涨超15%，截至发稿，涨15.22%，报23.02港元，成交额148.2万港元。消息面上，维升药业近日宣布，与中国领军医药多元支付平台镁信健康达成项目合作。双方将充分发挥各自在创新疗法与健康服务领域的资源优势，共同探索提升内分泌疾病创新疗法可及性与可支付性的多元路径，助力中国患者更便捷地获益于全球前沿的治疗方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1462152.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","02561","VXUS","BK1161","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648573101","title":"港股異動 | 維升藥業-B(02561.HK)早盤升逾15% 公司近期與鎂信健康達成項目合作 探索多元支付新模式","url":"https://stock-news.laohu8.com/highlight/detail?id=2648573101","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648573101?lang=zh_tw&edition=fundamental","pubTime":"2026-07-02 10:31","pubTimestamp":1782959502,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1161","02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648591439","title":"ESG獎項背後的價值錨點，是維升藥業-B(2561.HK)臨床價值與商業效率的雙重印證","url":"https://stock-news.laohu8.com/highlight/detail?id=2648591439","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648591439?lang=zh_tw&edition=fundamental","pubTime":"2026-07-01 11:22","pubTimestamp":1782876173,"startTime":"0","endTime":"0","summary":"从这个角度看，维升药业此次获得“ESG社会责任卓越企业”奖，更像是对其长期坚持临床价值导向的一次侧面体现。","market":"sg","thumbnail":"https://img7.gelonghui.com/column/6.png?guru_height=540&guru_width=375","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/6.png?guru_height=540&guru_width=375"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/5406425","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["02561","BK1161","ESG","159717"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647379633","title":"維升藥業-B(02561)6月29日斥資8.46萬港元回購4300股","url":"https://stock-news.laohu8.com/highlight/detail?id=2647379633","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647379633?lang=zh_tw&edition=fundamental","pubTime":"2026-06-29 19:59","pubTimestamp":1782734357,"startTime":"0","endTime":"0","summary":"智通财经APP讯，维升药业-B(02561)发布公告，于2026年6月29日，该公司斥资8.46万港元回购4300股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1460567.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1122246339","title":"維昇藥業-B 6月29日回購約0.43萬股，耗資約8.46萬港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1122246339","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122246339?lang=zh_tw&edition=fundamental","pubTime":"2026-06-29 19:57","pubTimestamp":1782734226,"startTime":"0","endTime":"0","summary":"维昇药业-B于2026年6月29日公布翌日披露报表，披露6月29日于香港联合交易所场内回购股份的具体信息。本次回购股份数量为4,300股，占回购前已发行股本约0.004%。回购价格每股介乎港币19.18元至港币20元，涉及总金额84,641港元，折合约8.46万港元。回购完成后，公司已发行股本为113,753,364股，库藏股数量增加至173,500股，总发行股本维持在113,926,864股。根据公告，公司确认已遵守香港联交所证券上市规则及相关法律法规。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"维昇药业-B 6月29日回购约0.43万股，耗资约8.46万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646357787","title":"維升藥業-B(02561)委任Roy Paul Khoury、Sherrie Lynn Glass及Michael J. Chang為非執行董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2646357787","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646357787?lang=zh_tw&edition=fundamental","pubTime":"2026-06-26 20:48","pubTimestamp":1782478120,"startTime":"0","endTime":"0","summary":"智通财经APP讯，维升药业-B(02561)发布公告，经股东于股东周年大会上批准后，委任Roy Paul Khoury先生、Sherrie Lynn Glass女士及Michael J. Chang先生为非执行董事已自2026年6月26日起生效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1459735.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02561","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167346466","title":"維昇藥業-B6月23日回購0.40萬股股份，涉資約7.68萬港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1167346466","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1167346466?lang=zh_tw&edition=fundamental","pubTime":"2026-06-23 20:15","pubTimestamp":1782216957,"startTime":"0","endTime":"0","summary":"维昇药业-B于2026年6月23日发布翌日披露报表，宣布于当日于香港联交所场内回购0.40万股普通股，占紧接回购前已发行股本约0.004%。该批股份每股回购价格介乎每股19.17港元至19.24港元，总金额约7.68万港元。回购授权于2025年6月27日获股东大会通过，公司依照授权可回购股份总数为11,392,686股，截至目前已在香港联交所或其他证券交易所合计回购169,200股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"维昇药业-B6月23日回购0.40万股股份，涉资约7.68万港元","news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02561"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2645783632","title":"維升藥業-B(02561)6月23日斥資約7.68萬港元回購4000股","url":"https://stock-news.laohu8.com/highlight/detail?id=2645783632","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645783632?lang=zh_tw&edition=fundamental","pubTime":"2026-06-23 20:13","pubTimestamp":1782216790,"startTime":"0","endTime":"0","summary":"智通财经APP讯，维升药业-B(02561)发布公告，于2026年6月23日该公司斥资约7.68万港元回购4000股，回购价格为每股19.17至19.24港元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1457716.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02561","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188480611","title":"維昇藥業-B：6月22日回購4,800股，涉資約9.50萬港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1188480611","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188480611?lang=zh_tw&edition=fundamental","pubTime":"2026-06-22 18:06","pubTimestamp":1782122805,"startTime":"0","endTime":"0","summary":"维昇药业-B于2026年6月22日发布公告称，公司当日通过香港联交所场内回购普通股4,800股，占此前已发行股本约0.004%，回购价格介乎每股19.80港元至19.81港元，总成交金额约9.50万港元。回购完成后，公司已发行股本为113,761,664股，库存股数量为165,200股。公告显示，该次股份回购依据2025年6月27日通过的购回授权进行。根据授权，公司可回购总数为11,392,686股，截至目前已累计回购165,200股；占购回授权通过时已发行股本的0.14501%。本公告由执行董事卢安邦签署。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"维昇药业-B：6月22日回购4,800股，涉资约9.50万港元","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02561"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":68,"code":"91000000","status":"200"}]}}